Skip to content
WeighLab
Menu

Methodology

The Cost-Efficiency Index, explained

Every GLP-1 provider on WeighLab is scored out of 100 on the same six weighted factors. The Index is a value-for-money model — it rewards the honest lowest cost of ownership, not the flashiest teaser rate. We apply the identical model to providers we earn a commission from and providers we don't, and we say which is which on every card. A score is our editorial judgment, built from each provider's public disclosures and our cost modeling; it is never sold.

The six factors & weights

01 Normalized Cost/Month

24%

The all-in monthly price, normalized against what you actually get — both molecules, adequate dosing, real access — so a low sticker on a stripped-down offer doesn't out-score honest value. This is a value metric, not a race to the cheapest teaser.

02 Price Transparency

20%

Whether the price is published up front and holds: no first-month teaser that silently triples, no undisclosed molecule, no membership, lab or consult fees stacked on after signup. A price you can't model is a price we mark down.

03 Nationwide Access

18%

How many states are actually served. All-50 coverage removes a coverage gamble; an undisclosed or narrow states list is a real risk to your total cost and continuity, and scores lower.

04 Formulation Options

14%

Breadth per dollar: both semaglutide and tirzepatide, brand-name (FDA-approved) availability where possible, and oral/sublingual routes for the needle-averse — more of the formulary reachable on one account.

05 Clinical Oversight

13%

Whether a licensed clinician — not just a form — stands behind the prescription, with real titration and side-effect support. Oversight is value you're paying for, so it's weighed alongside price.

06 Contract Flexibility

11%

How easily you can pause, switch or cancel. Auto-ship traps, coaching lock-ins and painful exits inflate the true cost of a program even when the monthly headline looks low.

Weights sum to 100%. Cost and transparency together carry 44% — because a value index that ignores whether you can actually trust the price isn't a value index. The six sub-scores are combined at these weights into the 0–100 Index rendered by our Index Meter, then translated to a letter grade for quick reading.

How we stay honest

This page is editorial information, not medical advice. Compounded GLP-1 medications are not FDA-approved finished drug products. Talk to a licensed clinician before starting any weight-management medication. Try the numbers yourself in our cost calculators, and see our affiliate disclosure and medical disclaimer.

← Back to the value leaderboard